Cannabis - Germany

Germany

Germany is projected to reach a revenue of €968.90m in the Cannabis market by 2024.
The revenue is expected to grow annually at a rate of 2.33%, leading to a market volume of €1,087.00m by 2029.
When compared globally, the United States is forecasted to generate the most revenue, amounting to €39,440.00m in 2024.
In terms of per person revenues in 2024, €0.05k are generated in relation to the total population figures.
Germany's growing acceptance and legalization of Cannabis are fueling a surge in investment opportunities in the German Cannabis market.

Key regions: United States, Canada, Netherlands, Germany, Thailand

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

Germany has seen a significant evolution in its Cannabis market in recent years, reflecting changing attitudes and regulations towards the industry.

Customer preferences: Customers in Germany are increasingly seeking out high-quality Cannabis products, driving demand for premium strains and products. With a growing awareness of the potential health benefits of Cannabis, there is a rising interest in medical Cannabis products among consumers. Convenience and discretion are also important factors for customers, leading to a surge in online sales and discreet packaging options.

Trends in the market: One notable trend in the German Cannabis market is the increasing availability of a diverse range of products, including oils, edibles, and topicals. This expansion of product offerings caters to different consumer preferences and consumption methods. Moreover, the market is witnessing a rise in domestic cultivation, reducing reliance on imports and supporting local producers. Collaborations between Cannabis companies and mainstream retailers are also on the rise, further normalizing Cannabis products in the market.

Local special circumstances: Germany's Cannabis market is heavily influenced by its strict regulatory framework, which has gradually been liberalized to allow for medical Cannabis use. The country has a well-established pharmaceutical industry, leading to a focus on quality and safety standards in Cannabis products. Additionally, the cultural acceptance of Cannabis for medical purposes has paved the way for further market growth and innovation in product development.

Underlying macroeconomic factors: The economic stability and high purchasing power of the German population have contributed to the growth of the Cannabis market. As one of the largest economies in Europe, Germany offers significant market potential for Cannabis companies. Furthermore, the country's progressive stance on Cannabis legalization and increasing public acceptance have created a favorable environment for market expansion.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.